Abstract:Multiple sclerosis is characterized by demyelination and neuronal loss caused by inflammatory cell activation and infiltration into the central nervous system. Macrophage polarization plays an important role in the pathogenesis of experimental autoimmune encephalomyelitis, a traditional experimental model of multiple sclerosis. This study investigated the effect of Fasudil on macrophages and examined the therapeutic potential of Fasudil-modified macrophages in experimental autoimmune encephalomyelitis. We found that Fasudil induced the conversion of macrophages from the pro-inflammatory M1 type to the anti-inflammatory M2 type, as shown by reduced expression of inducible nitric oxide synthase/nitric oxide, interleukin-12, and CD16/32 and increased expression of arginase-1, interleukin-10, CD14, and CD206, which was linked to inhibition of Rho kinase activity, decreased expression of toll-like receptors, nuclear factor-κB, and components of the mitogen-activated protein kinase signaling pathway, and generation of the pro-inflammatory cytokines tumor necrosis factor-α, interleukin-1β, and interleukin-6. Crucially, Fasudil-modified macrophages effectively decreased the impact of experimental autoimmune encephalomyelitis, resulting in later onset of disease, lower symptom scores, less weight loss, and reduced demyelination compared with unmodified macrophages. In addition, Fasudil-modified macrophages decreased interleukin-17 expression on CD4+ T cells and CD16/32, inducible nitric oxide synthase, and interleukin-12 expression on F4/80+ macrophages, as well as increasing interleukin-10 expression on CD4+ T cells and arginase-1, CD206, and interleukin-10 expression on F4/80+ macrophages, which improved immune regulation and reduced inflammation. These findings suggest that Fasudil-modified macrophages may help treat experimental autoimmune encephalomyelitis by inducing M2 macrophage polarization and inhibiting the inflammatory response, thereby providing new insight into cell immunotherapy for multiple sclerosis.

Rho Kinase Inhibitor Fasudil Regulates Microglia Polarization and Function.

Fasudil Regulates T Cell Responses Through Polarization of BV-2 Cells in Mice Experimental Autoimmune Encephalomyelitis

Fasudil-modified Macrophages Reduce Inflammation and Regulate the Immune Response in Experimental Autoimmune Encephalomyelitis.

The Immunoregulatory Effect of Rho Kinase Inhibitor Fasudil on Macrophages in a Mouse Model of ;experimental Autoimmune Encephalomyelitis

[Effect of Fasudil on the Phenotype Conversion of LPS-stimulated BV-2 Microglia].

The Inhibition of Rho Kinase Blocks Cell Migration and Accumulation Possibly by Challenging Inflammatory Cytokines and Chemokines on Astrocytes.

Inhibition of Rho‐kinase by Fasudil Protects Dopamine Neurons and Attenuates Inflammatory Response in an Intranasal Lipopolysaccharide‐mediated Parkinson's Model

Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer's disease mice via the downregulation of TLR4/Myd88/NF-κB pathway

[Fasudil improves cognition of APP/PS1 transgenic mice via inhibiting the activation of microglia and shifting microglia phenotypes from M1 to M2]

Targeting the Shift from M1 to M2 Macrophages in Experimental Autoimmune Encephalomyelitis Mice Treated with Fasudil.

Fasudil Protects Hippocampal Neurons Against Hypoxia-Reoxygenation Injury by Suppressing Microglial Inflammatory Responses in Mice.

Polarization of Macrophages and T Cells to Anti-Inflammation in EAE Mice Treated with Fasudil

Fasudil enhances the phagocytosis of myelin debris and the expression of neurotrophic factors in cuprizone-induced demyelinating mice

Rosmarinic Acid Regulates Microglial M1/M2 Polarization via the PDPK1/Akt/HIF Pathway Under Conditions of Neuroinflammation

Retracted: Effect of Fasudil on Remyelination Following Cuprizone‐induced Demyelination

Effect of Fasudil on Miroglia and Astrocytes in Experimental Autoimmune Encephalomyelitis Mice

Interferon Regulatory Factor 5 Mediates Lipopolysaccharide-Induced Neuroinflammation

The Phenotypic Conversion of Macrophage Detected by FACS in EAE Mice Treated with or Without Fasudil

Fasudil Mediates Cell Therapy of EAE by Immunomodulating Encephalomyelitic T Cells and Macrophages.

Fasudil-Triggered Phagocytosis of Myelin Debris Promoted Meylin Regeneration via the Activation of TREM2/DAP12 Signaling Pathway in Cuprizone-Induced Mice

Research on Macrophages, Tcells and TLR/NF- B Pathway in EAE Mice Treated with Oral Fasudil